Weiping Chen Selected Research

Colorectal Neoplasms (Colorectal Cancer)

9/2021

RNF6 promotes colorectal cancer invasion and migration via the Wnt/β-catenin pathway by inhibiting GSK3β activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Weiping Chen Research Topics

Disease

30	Neoplasms (Cancer) 08/2021 - 10/2008
6	Hepatocellular Carcinoma (Hepatoma) 10/2021 - 04/2012
6	Lung Neoplasms (Lung Cancer) 01/2021 - 03/2013
6	Osteoarthritis 09/2020 - 01/2014
6	Inflammation (Inflammations) 01/2020 - 06/2009
4	Neoplasm Metastasis (Metastasis) 01/2021 - 08/2014
3	Breast Neoplasms (Breast Cancer) 08/2021 - 10/2008
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2020 - 01/2019
3	Infections 10/2018 - 04/2012
3	Pre-Eclampsia (Preeclampsia) 01/2017 - 01/2015
2	Disease Resistance 10/2021 - 01/2014
2	Carcinoma (Carcinomatosis) 07/2021 - 01/2016
2	Carcinogenesis 01/2021 - 10/2008
2	Obesity 01/2020 - 07/2011
2	Acquired Immunodeficiency Syndrome (AIDS) 11/2019 - 01/2018
2	Body Weight (Weight, Body) 11/2019 - 03/2019
2	Hypoxia (Hypoxemia) 03/2018 - 01/2015
2	Metabolic Diseases (Metabolic Disease) 11/2017 - 04/2010
2	Rectal Neoplasms (Rectal Cancer) 04/2017 - 12/2016
2	Hepatitis 08/2015 - 05/2014
2	Myocardial Infarction 02/2012 - 10/2010
2	Multiple Myeloma 11/2010 - 02/2009
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 11/2010 - 02/2009
1	Proteinuria 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Ureteral Obstruction 01/2022
1	Disease Progression 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 09/2021
1	Triple Negative Breast Neoplasms 08/2021
1	Signet Ring Cell Carcinoma 07/2021
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 07/2021
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 07/2021
1	Appendiceal Neoplasms (Appendix Cancer) 07/2021
1	Necrosis 01/2021
1	Lymphatic Metastasis 01/2021
1	Extranodal Extension 01/2021
1	Aneuploidy (Aneuploid) 01/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020
1	COVID-19 01/2020
1	Feminization 12/2019
1	Shock 12/2019

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2007
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2015
7	Pharmaceutical PreparationsIBA 12/2019 - 02/2009
5	Messenger RNA (mRNA)IBA 01/2021 - 04/2012
4	Sirtuin 1IBA 10/2021 - 10/2008
4	Cisplatin (Platino)FDA LinkGeneric 03/2019 - 08/2014
4	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 07/2011
3	CateninsIBA 09/2021 - 09/2020
3	MicroRNAs (MicroRNA)IBA 01/2019 - 04/2017
2	ErbB Receptors (EGF Receptor)IBA 08/2021 - 01/2019
2	Protein Isoforms (Isoforms)IBA 01/2021 - 02/2014
2	Pyruvate KinaseIBA 01/2021 - 03/2018
2	Histones (Histone)IBA 01/2021 - 01/2016
2	Therapeutic UsesIBA 10/2020 - 08/2014
2	Biological ProductsIBA 11/2019 - 03/2019
2	Metformin (Glucophage)FDA LinkGeneric 11/2019 - 01/2017
2	PlatinumIBA 03/2019 - 12/2016
2	Carbon Nanotubes (Carbon Nanotube)IBA 12/2018 - 01/2017
2	Advanced Glycation End ProductsIBA 01/2017 - 07/2015
2	SoilIBA 03/2016 - 03/2011
2	LipidsIBA 11/2013 - 04/2010
2	Troponin T (Troponin T1)IBA 02/2012 - 10/2010
2	Proteasome InhibitorsIBA 11/2010 - 02/2009
2	Bortezomib (Velcade)FDA Link 11/2010 - 02/2009
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 01/2022
1	AlbuminsIBA 01/2022
1	Tissue Inhibitor of Metalloproteinase-1IBA 01/2022
1	tofersenIBA 01/2022
1	AntioxidantsIBA 10/2021
1	jasmonic acid (jasmonate)IBA 10/2021
1	EnzymesIBA 10/2021
1	Glutathione (Reduced Glutathione)IBA 10/2021
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 10/2021
1	Glycogen Synthase KinasesIBA 09/2021
1	Sorafenib (BAY 43-9006)FDA Link 01/2021
1	Heterogeneous Nuclear Ribonucleoprotein A1IBA 01/2021
1	Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	B7-H1 AntigenIBA 10/2020
1	SB 203580IBA 01/2020
1	CeramidesIBA 01/2020
1	dichlorobis(azomycin)platinum IIIBA 01/2020
1	cytosporone BIBA 01/2020
1	FR 180204IBA 01/2020
1	Tumor Biomarkers (Tumor Markers)IBA 01/2020
1	pyrazolanthroneIBA 01/2020
1	Orphan Nuclear ReceptorsIBA 01/2020
1	CarcinogensIBA 12/2019
1	CosmeticsIBA 12/2019
1	MetalsIBA 12/2019

Therapy/Procedure

10	Therapeutics 01/2021 - 11/2007
5	Drug Therapy (Chemotherapy) 07/2021 - 12/2016
4	Chinese Traditional Medicine (Traditional Chinese Medicine) 10/2020 - 05/2014
3	Operative Time 04/2017 - 01/2016
2	Chemoradiotherapy 04/2017 - 01/2016
1	Nephrectomy 01/2022
1	Metastasectomy 01/2021
1	Oral Administration 01/2021
1	Intra-Articular Injections 01/2020